Novavax, Inc. (NVAX) Reports Q2 Loss of $0.04
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $4.12 --0%
Revenue Growth %: +85.7%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MFON, SICP, LBAS, More
Revenue Growth %: +85.7%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.04), versus ($0.07) reported last year. Revenue for the quarter came in at $3 million versus the consensus estimate of $2.74 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shah Capital nominates two directors to board of Novavax (NVAX)
- Ericsson shares rise as Q1 report reveals strong earnings, gross margin beat
- PNC profit falls 21% amid weaker interest income
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
